Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center (U24 Clinical Trial Not Allowed)
Department of Health and Human Services
This Notice of Funding Opportunity (NOFO) invites applications for a Research Coordinating Center (RCC) to participate in a consortium of clinical centers that will test anti-obesity medication (AOM) treatment strategies for youth with obesity that maximize benefits and minimize risks of AOM use. Such intervention strategies should support the promotion of healthy growth and development; adequate nutritional status/intake, healthy eating and physical activity behaviors; mental health and well-being (e.g., body image, self-esteem, mood, etc.), and quality of life and be feasible to implement in clinical care settings. Priority areas include testing strategies to determine optimal developmenta
Funding
Award size
Not specified
Type
Cooperative Agreement
Dates
Deadline
Next 90 days
Posted
06/08/2026
Closes
2026-10-09
Eligibility
Eligibility
State governmentsSpecial district governmentsPrivate institutions of higher educationPublic housing authorities/Indian housing authoritiesCounty governmentsSmall businessesNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationCity or township governmentsIndependent school districtsNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationFor profit organizations other than small businessesOthers (see text field entitled "Additional Information on Eligibility" for clarification)Public and State controlled institutions of higher educationNative American tribal governments (Federally recognized)
Program
Funding area
Health - HL
Opportunity #
RFA-DK-27-136
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov